Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | 0.00% | +6.67% | +23.08% |
Mar. 27 | MediPharm Labs Narrows Q4 Loss, Revenue Grows; Up 10.5% | MT |
Mar. 27 | MediPharm Labs Narrows Q4 Loss, Revenue Grows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.08% | 23.61M | |
+37.08% | 5.92B | |
-17.43% | 4.51B | |
-9.46% | 3.15B | |
+0.51% | 3.1B | |
-3.53% | 2.42B | |
+41.15% | 1.97B | |
-5.15% | 1.68B | |
+0.09% | 1.65B | |
-10.38% | 1.53B |
- Stock Market
- Equities
- LABS Stock
- News MediPharm Labs Corp.
- MediPharm Labs : Health Canada Approves Start of Phase 2 Trial Using MediPharm Labs CBD Product; Falls 2.5% in Early Frankfurt Trading